Next 10 |
home / stock / extr / extr articles
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...
U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Monday. Shares of M&T Bank Corporation (NYSE: MTB) rose sharply d...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter ...
Extreme Networks, Inc. (NASDAQ:EXTR) shares are trading lower on Wednesday. The company reported a second-quarter FY24 revenue decline of...
Extreme Networks Inc (NASDAQ: EXTR) shares are tumbling today by over 6% after the company lowered its Q2 revenue guidance yesterday. The...
Needham analyst Alex Henderson reiterated Extreme Networks Inc (NASDAQ: EXTR) with a Buy and a $23 price target. Extreme is lik...
This year witnessed a strong rally in mega-tech stocks right from the beginning. After a brief pause in late summer, they regained moment...
Gainers Cellectis S.A. (NASDAQ: CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with As...
News, Short Squeeze, Breakout and More Instantly...
Extreme Networks Inc. Company Name:
EXTR Stock Symbol:
NASDAQ Market:
Extreme Networks Inc. Website:
Previews Extreme AI Expert: A Futuristic Way to Design, Optimize and Deploy Networks Extreme Connect — Extreme Networks , Inc. (Nasdaq: EXTR), a leader in cloud networking, today announced the launch of Extreme Labs : a dynamic ecosystem where creativity, collaboratio...
Cedar Fair, San Francisco Giants and Brigham Young University (BYU) among industry’s first significant customer deployments for outdoor 6 GHz Extreme Connect — Extreme Networks , Inc. (Nasdaq: EXTR), a leader in cloud networking, today announced that it’s th...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...